Patient and Family Financial burden in Life

Patient and Family Financial burden in Life - PaFFL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060942

Enrollment

1000

Registered

2026-03-16

Start date

2025-12-16

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with cancer who are receiving or have received cancer treatment Individuals able to respond to the questionnaire Individuals who provide written or electronic informed consent Family members or primary caregivers supporting patients with cancer

Exclusion criteria

Exclusion criteria: Individuals who are unable to complete the questionnaire as judged by the investigator Individuals who do not provide informed consent

Design outcomes

Primary

Measure	Time frame
The primary outcome is the degree of financial toxicity assessed using the Japanese version of the Comprehensive Score for Financial Toxicity (COST). Financial toxicity will be evaluated based on COST scores obtained from the questionnaire survey, and the distribution and severity of financial toxicity among patients with cancer and their family members will be analyzed.	—

Countries

Japan

Contacts

Public ContactKazunori Honda

Aichi Cancer Center Department of Clinical Oncology

khonda@aichi-cc.jp052-762-6111

Outcome results